MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
BioRestorative Therapies, Inc. Common Stock (NV)

BRTX

#4517
BioRestorative Therapies, Inc. - Common Stock
0.4 8 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.48
0.48
Year Range
0.16
2.04
Daily Change
0.00%
Monthly Change
+128.57%
6 month change
-57.52%
Year Change
-73.03%
Previous Close
0.4 8
Open
0.4 8
Low
0.4 8
High
0.4 8
Volume
3
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. BRTX
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 12.23 M
  • Employee 14
  • Founded 1997
  • CEO N/A
  • Website www.biorestorative.com
  • Headquarter Nevada, United States
  • FIGI BBG000BNB165
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.74
Price to sales ratio
16.88

News

Zacks Zacks
BRTX
2026.05.15
What Makes Biorestorative Therapies (BRTX) a New Buy Stock
Zacks Zacks
BRTX MDWD
2026.05.14
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates
Zacks Zacks
CHRS BRTX
2026.05.11
Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates
Zacks Zacks
PTCT BRTX
2026.05.07
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
Zacks Zacks
GERN BRTX
2026.05.06
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
Zacks Zacks
BRTX
2026.04.27
Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing
Zacks Zacks
BRTX RNXT
2026.03.26
Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates
Zacks Zacks
ABSI BRTX
2026.03.24
Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates
Zacks Zacks
ETON BRTX
2026.03.19
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates
Zacks Zacks
GLUE BRTX
2026.03.17
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates
Investing Investing
BRTX
2026.02.14
BioRestorative Therapies closes $5 million public offering
Investing Investing
BRTX
2025.11.13
BioRestorative Therapies earnings beat by $0.05, revenue fell short of estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd